163 related articles for article (PubMed ID: 1781384)
41. [Adenylosuccinase deficiency].
Fujimori S
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):441-3. PubMed ID: 9590095
[No Abstract] [Full Text] [Related]
42. [Muscle AMP deaminase deficiency].
Kaletha K; Nowak G; Adrych K; Makarewicz W
Postepy Biochem; 1991; 37(2):58-62. PubMed ID: 1819795
[No Abstract] [Full Text] [Related]
43. Effect of hepatocarcinogens on the adenine purine nucleotide cycle during the initiation phase of carcinogenesis.
Smith LD; Emerson RL; Nixon LK
Cancer Res; 1979 Jun; 39(6 Pt 1):2132-8. PubMed ID: 445410
[TBL] [Abstract][Full Text] [Related]
44. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.
Sabina RL; Swain JL; Olanow CW; Bradley WG; Fishbein WN; DiMauro S; Holmes EW
J Clin Invest; 1984 Mar; 73(3):720-30. PubMed ID: 6707201
[TBL] [Abstract][Full Text] [Related]
45. Disorders of purine biosynthesis metabolism.
Dewulf JP; Marie S; Nassogne MC
Mol Genet Metab; 2022 Jul; 136(3):190-198. PubMed ID: 34998670
[TBL] [Abstract][Full Text] [Related]
46. Pediatric neurological syndromes and inborn errors of purine metabolism.
Camici M; Micheli V; Ipata PL; Tozzi MG
Neurochem Int; 2010 Feb; 56(3):367-78. PubMed ID: 20005278
[TBL] [Abstract][Full Text] [Related]
47. Disruption of the purine nucleotide cycle. A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency.
Sabina RL; Swain JL; Patten BM; Ashizawa T; O'Brien WE; Holmes EW
J Clin Invest; 1980 Dec; 66(6):1419-23. PubMed ID: 7440723
[TBL] [Abstract][Full Text] [Related]
48. Clinical, biochemical and molecular findings in seven Polish patients with adenylosuccinate lyase deficiency.
Jurecka A; Zikanova M; Tylki-Szymanska A; Krijt J; Bogdanska A; Gradowska W; Mullerova K; Sykut-Cegielska J; Kmoch S; Pronicka E
Mol Genet Metab; 2008 Aug; 94(4):435-442. PubMed ID: 18524658
[TBL] [Abstract][Full Text] [Related]
49. Adenylosuccinase deficiency: clinical and biochemical findings in 5 Czech patients.
Sebesta I; Krijt J; Kmoch S; Hartmannová H; Wojda M; Zeman J
J Inherit Metab Dis; 1997 Jul; 20(3):343-4. PubMed ID: 9266351
[No Abstract] [Full Text] [Related]
50. Adenylosuccinate lyase deficiency.
Jurecka A; Zikanova M; Kmoch S; Tylki-Szymańska A
J Inherit Metab Dis; 2015 Mar; 38(2):231-42. PubMed ID: 25112391
[TBL] [Abstract][Full Text] [Related]
51. Overview of possible relation of defects in purine metabolism to immune deficiency.
Seegmiller JE
Ann N Y Acad Sci; 1985; 451():9-19. PubMed ID: 3935028
[No Abstract] [Full Text] [Related]
52. Failure of D-ribose in myoadenylate deaminase deficiency.
Lecky BR
Lancet; 1983 Jan; 1(8317):193. PubMed ID: 6130241
[No Abstract] [Full Text] [Related]
53. Preparation of 5-amino-4-imidazole-N-succinocarboxamide ribotide, 5-amino-4-imidazole-N-succinocarboxamide riboside and succinyladenosine, compounds usable in diagnosis and research of adenylosuccinate lyase deficiency.
Zikánová M; Krijt J; Hartmannová H; Kmoch S
J Inherit Metab Dis; 2005; 28(4):493-9. PubMed ID: 15902552
[TBL] [Abstract][Full Text] [Related]
54. Disorders associated with purine and pyrimidine metabolism.
Edwards NL; Fox IH
Spec Top Endocrinol Metab; 1984; 6():95-140. PubMed ID: 6098039
[TBL] [Abstract][Full Text] [Related]
55. Adenylosuccinate lyase deficiency affects neurobehavior via perturbations to tyramine signaling in Caenorhabditis elegans.
Moro CA; Sony SA; Franklin LP; Dong S; Peifer MM; Wittig KE; Hanna-Rose W
PLoS Genet; 2023 Sep; 19(9):e1010974. PubMed ID: 37773959
[TBL] [Abstract][Full Text] [Related]
56. Genetic basis of adenylosuccinase deficiency in an Italian patient.
Verginelli D; Luckow B; Salerno C; Gross M
Adv Exp Med Biol; 1998; 431():323-5. PubMed ID: 9598084
[No Abstract] [Full Text] [Related]
57. Myoclonic tremor status as a presenting symptom of adenylosuccinate lyase deficiency.
Andelman-Gur MM; Saitsu H; Matsumoto N; Spiegel R; Yosovich K; Lev D; Lerman-Sagie T; Blumkin L
Eur J Med Genet; 2020 Dec; 63(12):104061. PubMed ID: 32890691
[TBL] [Abstract][Full Text] [Related]
58. Adenylosuccinate lyase deficiency.
Spiegel EK; Colman RF; Patterson D
Mol Genet Metab; 2006; 89(1-2):19-31. PubMed ID: 16839792
[TBL] [Abstract][Full Text] [Related]
59. Deficiency of erythrocyte type isozyme of AMP deaminase in human.
Ogasawara N; Goto H; Yamada Y; Hasegawa I
Adv Exp Med Biol; 1986; 195 Pt A():123-7. PubMed ID: 3728146
[No Abstract] [Full Text] [Related]
60. The need for vigilance: false-negative screening for adenylosuccinate lyase deficiency caused by deribosylation of urinary biomarkers.
Krijt J; Skopova V; Adamkova V; Cermakova R; Jurecka A; Kmoch S; Zikanova M
Clin Biochem; 2013 Dec; 46(18):1899-901. PubMed ID: 24183879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
